丹参川芎嗪注射液治疗椎-基底动脉供血不足的临床观察  

The clinical observation on the treatment of vertebro-basilar insufficiency with Salvia Tetramethylpyrazine Injection

作　　者：张仁汉[1] 赵东玲[1] 李瑞林[1] 

机构地区：[1]西安交通大学医院,西安710061

出　　处：《西北药学杂志》2012年第4期358-359,共2页Northwest Pharmaceutical Journal

摘　　要：目的观察丹参川芎嗪注射液在治疗椎-基底动脉供血不足(VBI)中的疗效。方法对该院近6年收治的120例VBI患者随机分组,观察组60例用丹参川芎嗪注射液15d,对照组60例用血塞通注射液15d。结果观察组总有效率为86.7%(P<0.05),对照组总有效率为60.0%。结论丹参川芎嗪注射液治疗VBI效果显著且安全。Objective To observe the efficacy of Salvia Tetramethylpyrazine Injection in the treatment of vertebro-basilar insufficiency （VBI）. Methods 120 VBI cases treated in our hospital in recent 6 years were randomly divided into observation group and control group. Salvia Tetramethylpyrazine Injection was used to 15 d 60 cases in the observation group while Xuesaitong Injection was used to 15 d 60 cases in the control group. Results The total effective rate of the observation group the control group were 86.7% （P〈 0.05 ） and 60.0 %, respectively. Conclusion Salvia Tetramethylpyrazine Injection is effective and safe in treating VBI.

关 键 词：中老年人多发病 椎-基底动脉供血不足 丹参川芎嗪注射液 

分 类 号：R972[医药卫生—药品]